Media Spotlight

During June 2006, 76 media placements about The University of Texas Health Science Center at Houston reached a potential audience of nearly 14 million people. The following is a sample of those media placements.

Dr. Ruben Quiros says he sees cases of nonalcoholic fatty liver disease – once considered strictly an adult condition – among preadolescents and teens, Houston Chronicle “Health/Medicine” Page, June 1.

In an article about recent studies of alcohol use by pregnant woman, Dr. Raul Caetano says, to avoid harm to an unborn child, “If you want to drink and you are sexually active, the best thing to do is to use contraception,” Time Magazine, June 5.

The FDA has approved a new vaccine (Zostavax by Merck) that researcher Dr. Stephen Tyring says could prevent shingles, Houston Chronicle “Health/Medicine” Page, June 15.

Dr. Samer Fakhri’s high-tech minimally invasive surgery is successfully removing brain tumors without cracking open the skull, KHOU-TV’s “11 News at Five,” June 12.

The UT School of Public Health’s Institute for Health Policy leads a task force of eight scientists from five institutions reporting to Mayor Bill White on the region’s worst air pollutants, giving the city a cleanup “to-do” list, Houston Chronicle Front Page and KUHF-FM and KTRH-AM radio, June 12-13.

Dr. Thomas O. Clanton tells about using the Carolina Jones Fracture System during Rockets superstar Yao Ming’s foot surgery, KRIV-TV’s “Fox 26 News at Nine,” June. 19.

Dr. Maureen Mayes says a new scleroderma study in which she participated offers hope of developing a substance “that would either attack anti-PDGFR protein or render it inactive,” Wall Street Journal, June 22.

Lead researcher Dr. Jerry Wolinsky says his landmark study finds that daily injections of glatiramer acetate (Copaxone) appear to slow the progression of multiple sclerosis in patients who continue this therapy over a long period of time, KTRK-TV’s “Live at Five,” June 27.